See every side of every news story
Published loading...Updated

Proscia raises $50M for AI-driven pathology - Drug Discovery and Development

Summary by Drug Discovery and Development
Digital pathology software developer Proscia raised $50 million in new funding to accelerate the adoption of its AI-powered pathology platform. The Series C fundraising round was led by Insight Partners, with participation from AI Capital Partners, Triangle Peak Partners and several other healthcare-focused investors. The financing brings Proscia’s total capital raised to $130 million. Proscia… The post Proscia raises $50M for AI-driven patholog…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Drug Discovery and Development broke the news in on Friday, March 21, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.